JP TSE 219A Pharmaceutical

Heartseed株式会社

Fiscal year ends
Oct
Latest results
FY ending Dec 2025
Employees
43
Revenue
¥3.0B
≈ $19.2M
Net income
¥191M
≈ $1.2M
Total assets
¥7.7B
≈ $48.6M
Equity ratio
93.7%
 

Share price at fiscal year-end: ¥1,841 · market capitalization ¥42.1B · P/E 218.1 · P/B 5.85

US dollar amounts use ¥157.8 per dollar.

Annual results

Fiscal yearRevenueNet incomeTotal assetsNet assetsEquity ratioSource
Dec 2025¥3.0B¥191M ¥7.7B¥7.2B93.7% EDINET
Dec 2024¥874M−¥813M ¥7.1B¥6.6B93.7% EDINET
Dec 2023¥345M−¥1.5B ¥5.7B¥5.3B92.1% EDINET
Dec 2022¥499M−¥1.4B ¥4.9B¥4.7B95.8% EDINET
Dec 2021¥1.6B−¥258M ¥6.3B¥6.1B97.2% EDINET

From annual securities reports filed with the Financial Services Agency's EDINET. 日本語のページ(同業比較・役員)

Compare with the world's largest companies

See where Japanese companies stand in the world rankings by revenue, profit and taxes paid.

World rankings